中美贸易战美国仅剩一张牌，而中国至少有“土豆药债”四个王炸

Core Viewpoint - The announcement of a 100% tariff on Chinese goods by Trump marks a significant escalation in the US-China trade war, potentially leading to severe impacts on high-end manufacturing in China, particularly in the semiconductor sector [1] Group 1: Trade Tariffs and Responses - The US's proposed tariffs could increase the total tariffs on Chinese goods to 130%, which may severely affect China's high-end manufacturing capabilities [1] - China is prepared to respond with equivalent tariffs on US goods, particularly targeting the service trade where the US has a significant surplus [3] - The US has delayed previous negotiations due to concerns over inflation, unemployment, and supply chain issues, indicating a reluctance to engage in a full-scale trade confrontation [3] Group 2: Rare Earth Elements - China controls 70% of global rare earth mining and 90% of processing, making it a critical player in high-tech manufacturing [5] - Recent upgrades to China's rare earth export controls include restrictions on any foreign production using Chinese technology and a comprehensive control over the entire supply chain [5] - The US military heavily relies on Chinese rare earths, with a report indicating that 87% of its supply chain has critical vulnerabilities [5][6] Group 3: Agricultural Impact - China, as the largest consumer of soybeans, has ceased purchasing US soybeans since May 2025, leading to significant financial distress for US farmers [9] - The halt in soybean purchases has resulted in 7 million tons of unsold soybeans and the bankruptcy of 12,000 farmers in the Midwest [9] - The urgency for Trump to persuade China to resume soybean purchases is heightened by the upcoming midterm elections, as farmers threaten to withdraw support for the Republican Party [9] Group 4: Pharmaceutical Industry - China dominates the production of active pharmaceutical ingredients (APIs), supplying 23% of the US's API imports [11] - A 100% tariff on Chinese APIs could lead to increased drug costs and exacerbate shortages in the US market, prompting pharmaceutical companies to consider relocating production [11][12] - The potential rise in drug prices could significantly impact low-income families' access to healthcare, raising concerns among US lawmakers [12] Group 5: US Debt and Financial Stability - The US national debt has surpassed $37 trillion, with China reducing its holdings of US Treasury bonds to $730.7 billion, the lowest since 2008 [14] - This reduction in US debt holdings by China signals a potential financial risk for the US and has contributed to market instability [14] - The shift towards de-dollarization is evident as China seeks to establish alternative currency arrangements with countries like Brazil, Saudi Arabia, and Russia [14] Group 6: Global Financial Dynamics - The ongoing trends indicate a significant shift in global financial power, with the renminbi gaining acceptance as an international currency [14] - The erosion of the US's financial dominance is highlighted by the increasing use of the renminbi in global transactions, particularly in energy markets [14][15] - The combination of these factors suggests a profound transformation in the global monetary system, moving towards a multi-currency framework [14][15]